鶹Ů

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 鶹Ů Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida’s KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida’s KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jul 11 2016

Full Issue

OxyContin-Maker Purdue Kept Quiet While Los Angeles Drug Ring Thrived

The drugmaker tracked the clinic that was prescribing a jaw-dropping amount of OxyContin — one employee wrote in an email: "I feel very certain this is an organized drug ring...” — but said nothing to the DEA until years later. Meanwhile the Los Angeles Times also looks at the Washington city that was ravaged by the drug ring.

In the waning days of summer in 2008, a convicted felon and his business partner leased office space on a seedy block near MacArthur Park. They set up a waiting room, hired an elderly physician and gave the place a name that sounded like an ordinary clinic: Lake Medical. The doctor began prescribing the opioid painkiller OxyContin – in extraordinary quantities. In a single week in September, she issued orders for 1,500 pills, more than entire pharmacies sold in a month. In October, it was 11,000 pills. By December, she had prescribed more than 73,000, with a street value of nearly $6 million. (Ryan, Glover and Girion, 7/10)

For years, Jevon “Goldie” Lawson dealt crack on the steps of a 7-Eleven in a rough part of this blue-collar town. He smoked the rocks he didn’t sell and often appeared as strung out as his customers. But in 2008, he moved into a $400,000 house, started driving a champagne-colored Humvee, and made himself the star act of his own hip-hop label. He abandoned the crack business. Found something better, he told associates. (Ryan, Glover and Girion, 7/10)

In other news, it's likely Congress will pass its opioid package despite funding disputes and doctors continue to try to balance patients' pain treatments with opioid regulations —

Congress this week is expected to send President Obama legislation to combat heroin and painkiller abuse, despite lingering disputes over whether there is enough funding to support new treatment and prevention programs. Senate Democrats have pushed for additional funding arguing that without it the bill will not be able to deliver on its promise to help thwart the opioid epidemic. But they do not plan to block the agreement that House and Senate negotiators finalized last week, according to a spokesman for Minority Leader Harry Reid (D-Nev.). It’s unclear how many Democrats will support the bill, but it is expected to easily be approved just in time for the height of the election season. (Demirjian, 7/11)

The House overwhelmingly approved a compromise package bolstering federal steps against illicit drugs on Friday, as lawmakers of both parties flocked to cast an election-year vote to stem the nation's surge of deaths among drug abusers. The legislation was approved 407-5, underscoring the broad support it has attracted to combat a problem that claims victims across racial, economic and geographic lines. (Fram, 7/8)

Republicans dared House Democrats to block an opioids bill over a lack of funding, and the Democrats blinked. Now the Comprehensive Addiction and Recovery Act — legislation that’s a political priority for lawmakers in both parties and key to the reelection bids of vulnerable Senate Republicans — heads to the Senate next week with a full head of steam after a 407-5 landslide vote to approve it in the House on Friday. (Norman, 7/8)

If you have chronic pain, you might be hearing about more treatment options from your doctor soon. Greater Cincinnati primary care doctors have a chance to learn more ways to manage chronic pain, thanks to a no-fuss, no-cost UC Health program. Nearly a dozen UC Health specialists are on hand monthly for a virtual mentoring program that gives doctors tips about treating pain –often without prescribing opioids. At first, the program was offered to the health organization's primary care physicians, but now, it's open to any physician groups in the region. (DeMio, 7/9)

Doctors have long complained about patients demanding inappropriate treatment, especially addictive opioid painkillers. Many say they feel forced to comply for fear they will be rated poorly by patients on the internet or even more official surveys. (Sapatkin, 7/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 鶹Ů